TJP1 and cancer: First, it improves the infiltration of chemotherapy drugs into the deep cancer tissue by interfering with ZO-1 and E-cadherin expression, resulting in changes to their permeability; second, it increases the intracellular drug level by reducing the expression of cisplatin efflux membranous protein (MDR-1).